Showing results (71-80 of 599) with videos related to
Sort By:
Pageof 60
Plos Computational Biology|September 15, 2009
Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinibJasmine Foo, Mark W Drummond, Bayard Clarkson, et al.Cancer Research|June 21, 2020
Pharmacokinetic Profiles Determine Optimal Combination Treatment Schedules in Computational Models of Drug ResistanceItziar Irurzun-Arana, Thomas O McDonald, Iñaki F Trocóniz, et al.Seminars in Cancer Biology|December 23, 2004
Can chromosomal instability initiate tumorigenesis?Franziska Michor, Yoh Iwasa, Bert Vogelstein, et al.Cell Cycle (Georgetown, Tex.)|January 17, 2004
Linear model of colon cancer initiationFranziska Michor, Yoh Iwasa, Harith Rajagopalan, et al.JCO Clinical Cancer Informatics|March 23, 2019
Stochastic Evolution of Pancreatic Cancer Metastases During Logistic Clonal ExpansionKimiyo N Yamamoto, Lin L Liu, Akira Nakamura, et al.Plos One|September 21, 2011
The probable cell of origin of NF1- and PDGF-driven glioblastomasDolores Hambardzumyan, Yu-Kang Cheng, Hiroshi Haeno, et al.JCO Clinical Cancer Informatics|January 18, 2019
Computational Model of Progression to Multiple Myeloma Identifies Optimum Screening StrategiesPhilipp M Altrock, Jeremy Ferlic, Tobias Galla, et al.The Journal of Clinical Investigation|January 27, 2010
Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotypeSo Yeon Park, Mithat Gönen, Hee Jung Kim, et al.Expert Review of Anticancer Therapy|July 24, 2004
Anagrelide: an update on its mechanisms of action and therapeutic potentialDavid Dingli, Ayalew TefferiLeukemia & Lymphoma|July 16, 2005
A critical review of anagrelide therapy in essential thrombocythemia and related disordersDavid Dingli, Ayalew TefferiPageof 60